<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944161</url>
  </required_header>
  <id_info>
    <org_study_id>01_2019</org_study_id>
    <nct_id>NCT03944161</nct_id>
  </id_info>
  <brief_title>Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain</brief_title>
  <acronym>COSENUT</acronym>
  <official_title>Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociación Española de Fabricantes y Distribuidores de Productos de Nutrición Enteral</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>WEBER Economía y Salud S.L.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asociación Española de Fabricantes y Distribuidores de Productos de Nutrición Enteral</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims to evaluate the use of oral nutritional supplementation in persons
      with some clinical conditions presenting malnutrition in some extent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COSNUT pretends to assess the cost-effectiveness and cost-utility of oral nutritional
      supplementation (ONS) in persons with malnutrition and other clinical conditions. The
      effectiveness will be evaluated by comparing the intervention group having ONS vs a control
      group only with nutrition advice. The effectiveness and resource use will be collected using
      quality of life assessment tools, body mass index, change in malnutrition state, number of
      hospital admissions, medical visits...

      Unitary costs for Spain will be extracted from databases and official publications and will
      be applied to the number of resources used in order to calculate the costs in each of the
      groups. Finally, the incremental cost-effectiveness ratio will be estimated and presented.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>baseline</time_frame>
    <description>Index for relating weight to height. Abbreviated BMI. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>12 weeks</time_frame>
    <description>Index for relating weight to height. Abbreviated BMI. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>6 months</time_frame>
    <description>Index for relating weight to height. Abbreviated BMI. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in nutritional status</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>Change in the Global Subjective Assessment (this scale categorize participants into A, B or C being A the best nutritional status and C the worst.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in nutritional status</measure>
    <time_frame>from basal-6 months</time_frame>
    <description>Change in the Global Subjective Assessment (this scale categorize participants into A, B or C being A the best nutritional status and C the worst.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants Diagnosed of malnutrition</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>Diagnosis of malnutrition using GLIM criteria</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants Diagnosed of malnutrition</measure>
    <time_frame>from baseline-6 months</time_frame>
    <description>Diagnosis of malnutrition using GLIM criteria</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>EuroQoL 5 dimensions and 5 levels(EQ5D5L) (scale between 0 which is the death and 1 which is the best health status)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>from baseline-6 months</time_frame>
    <description>EuroQoL 5 dimensions and 5 levels(EQ5D5L) (scale between 0 which is the death and 1 which is the best health status)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional status</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>Katz index (this index categorize in one of 7 categories: A,B,C,D,E,F,G from independent for all functions (A) to dependent for all functions (G))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional status</measure>
    <time_frame>from baseline-6 months</time_frame>
    <description>Katz index (this index categorize in one of 7 categories: A,B,C,D,E,F,G from independent for all functions (A) to dependent for all functions (G))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strength and endurance</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>30-second Chair Stand Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strength and endurance</measure>
    <time_frame>from baseline-6 months</time_frame>
    <description>30-second Chair Stand Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strength</measure>
    <time_frame>from baseline-12 weeks</time_frame>
    <description>hand grip strength test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strength</measure>
    <time_frame>from baseline-6 months</time_frame>
    <description>hand grip strength test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Hospital admittance</measure>
    <time_frame>at 30 days</time_frame>
    <description>Number of admittance from randomization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Hospital admittances</measure>
    <time_frame>from randomization to 6 months</time_frame>
    <description>Number of admittance from randomization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Medical doctor visits</measure>
    <time_frame>from randomization to 6 months</time_frame>
    <description>Visits to any outpatient medical office</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of deaths</measure>
    <time_frame>from randomization to 6 months</time_frame>
    <description>mortality registry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infections</measure>
    <time_frame>at 6 months</time_frame>
    <description>Any diagnosed infection by a medical doctor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of secondary effects related to the intervention</measure>
    <time_frame>from randomization to 6 months</time_frame>
    <description>Any undesirable effect due to the intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Malnutrition</condition>
  <condition>Nutrition Disorders</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the intervention group will receive an oral nutrition supplement bottle (200/220 ml) with &gt;20 % of protein and 1.5 Kcal/ml without fibre twice a day during 12 weeks and nutritional advice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the control group will receive nutrition advice</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral nutrition supplement</intervention_name>
    <description>Hypercaloric and high protein supplement</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional advice</intervention_name>
    <description>Advice given by the clinician</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 y

          -  Nutritional status B or C (GSA criteria)

          -  Presenting one of the following conditions:

          -  Cancer patient after surgery, radiotherapy on antineoplastic treatment.

          -  Hip fracture

          -  Heart failure NYHA (New York Heart Association) III-IV.

          -  Breathing failure GOLD 3 o 4: FEV1 (forced expiratory volume at one second ) &lt;50%.

          -  Renal failure GFR&lt;30 (glomerular filtration rate )

          -  Participants agreeing the informed consent

        Exclusion Criteria:

          -  Cancer patients: esophagus, stomach, pancreas and Head and neck

          -  Hospital admitted patients at the time of recruitment

          -  Life expectancy below 3 months

          -  Pregnant or nursing women

          -  Use of oral nutritional supplements in the three months prior the enrolment

          -  History of allergy to oral nutritional supplements

          -  Diabetes mellitus type 1.

          -  Participation in any other study at the time of enrolment

          -  Cognitive limitations to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Complejo Hospitalario Regional Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <state>Andalucía</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mª José Molina Puerta, MD</last_name>
      <phone>+34 957012960</phone>
      <email>cmmerinomjmolina@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <state>Aragón</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Ocón Bretón, MD</last_name>
      <phone>+34 699845828</phone>
      <email>mjocon@salud.aragon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de León</name>
      <address>
        <city>León</city>
        <state>Castilla Y León</state>
        <zip>24008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Urioste Fondo, MD</last_name>
      <phone>+34 987 23 49 00</phone>
      <email>anaurifon@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial de Segovia</name>
      <address>
        <city>Segovia</city>
        <state>Castilla Y León</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Abreu Padín, MD</last_name>
      <phone>+34 921 41 91 00</phone>
      <email>cabreupadin@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias I Pujol de Badalona</name>
      <address>
        <city>Badalona</city>
        <state>Cataluña</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Analía Ramos, MD</last_name>
      <phone>+34 93 497 8653</phone>
      <email>aeramos.germanstrias@gencat.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Joan Xxiii de Tarragona</name>
      <address>
        <city>Tarragona</city>
        <state>Cataluña</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Solano Fraile, MD</last_name>
      <phone>+34 977 29 58 00</phone>
      <phone_ext>1615</phone_ext>
      <email>esolano.hj23.ics@gencat.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Nuestra Señora Del Prado</name>
      <address>
        <city>Talavera De La Reina</city>
        <state>Toledo</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benito Blanco Samper, MD</last_name>
      <phone>+34925803600</phone>
      <phone_ext>86050</phone_ext>
      <email>bblancosamper@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nutritional supplement</keyword>
  <keyword>cost-effectiveness</keyword>
  <keyword>cost-utility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

